Task: Answer the multiple choice question.
Question: Which drug exhibits a -34.296% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC1CCN(c2oc(-c3ccc(F)cc3)nc2C#N)CC1
b N#Cc1c2n(c3c(=O)n(Cc4ccccc4Cl)cnc13)CCCC2
c CC(=O)N1c2ccc(S(=O)(=O)NCCC(=O)NCCc3ccc(C)cc3)cc2CC1C
Answer: b. N#Cc1c2n(c3c(=O)n(Cc4ccccc4Cl)cnc13)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c2n(c3c(=O)n(Cc4ccccc4Cl)cnc13)CCCC2
N#Cc1c2n(c3c(=O)n(Cc4ccccc4Cl)cnc13)CCCC2
3-[(2-chlorophenyl)methyl]-4-oxo-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile